Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02620865
Title Bispecific Antibody Armed Activated T-cells With Aldesleukin and Sargramostim in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Barbara Ann Karmanos Cancer Institute
Indications

pancreatic adenocarcinoma

Therapies

Paclitaxel

Aldesleukin

Oxaliplatin

Sargramostim

Gemcitabine

Fluorouracil + Leucovorin

Age Groups: adult
Covered Countries USA


No variant requirements are available.